对比剂-生理盐水混合双流注射方案用于低千伏CT血管成像:系统体模与动物研究
在循环体模和5只哥廷根小型猪中比较三种注射方案行动态胸部CTA:80 kV双流(DF)方案碘流率0.9 gI/s、5 mL/s、碘普罗胺与生理盐水60%/40%混合、对比剂剂量180 mgI/kg体重;120 kV参考方案碘流率1.5 gI/s、5 mL/s碘普罗胺、无同步生理盐水、300 mgI/kg体重;80 kV常规单流(SF)方案碘流率0.9 gI/s、3 mL/s碘普罗胺、无同步生理盐水、180 mgI/kg体重。DF方案可针对低kV CTA调整,在总流率不变下降低碘流率,虽衰减无差异但达峰时间更短、更接近120 kV参考方案。
要点
- 80 kV DF方案与80 kV SF及120 kV SF参考方案的肺动脉和主动脉时间衰减曲线无显著差异。
- 动物模型中80 kV DF方案肺动脉和主动脉峰值强化与120 kV SF及80 kV SF方案相似。
- 80 kV DF方案达峰时间较80 kV SF方案显著缩短(15.78±1.9秒 vs 18.24±2.0秒,P=0.008)。
核心结论
- 双流注射方案可通过降低碘流率而保持总流率不变来适配低kV CTA。
- 虽未发现衰减差异,DF注射达峰时间更短、更接近120 kV参考方案,可用于校准低kV CTA的团注密度并有望实现更个体化的对比剂给药。
研究设计与样本
- 系统体模与动物研究,动物模型为5只哥廷根小型猪,行动态胸部CTA。
- 比较三种注射方案:80 kV DF方案(碘流率0.9 gI/s、流率5 mL/s、碘普罗胺300 mgI/mL与生理盐水60%/40%混合、对比剂剂量180 mgI/kg体重)。
- 120 kV参考CTA方案(碘流率1.5 gI/s、流率5 mL/s碘普罗胺300 mgI/mL、无同步生理盐水、剂量300 mgI/kg体重)。
- 80 kV常规单流方案(碘流率0.9 gI/s、流率3 mL/s碘普罗胺300 mgI/mL、无同步生理盐水、剂量180 mgI/kg体重)。
- 三种方案后均以对应对比剂注射相同流率给予生理盐水冲管,并生成肺动脉干与降主动脉的时间衰减曲线以代表血管团注形态。
关键影像表现/征象
- 循环体模中80 kV DF方案的肺动脉和主动脉时间衰减曲线与80 kV SF及120 kV SF参考方案无显著差异。
- 动物模型中80 kV DF方案肺动脉和主动脉峰值强化与120 kV SF及80 kV SF方案相似。
- 衰减水平高于300 HU的团注长度在各注射方案间无显著差异。
- 80 kV DF方案达峰时间较80 kV SF方案显著缩短(15.78±1.9秒 vs 18.24±2.0秒,P=0.008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was to evaluate a contrast media (CM)-saline mixture administration with DualFlow (DF) to adapt injection protocols to low-kilovolt (kV) computed tomography angiography (CTA).
MATERIALS AND METHODS: In both a circulation phantom and animal model (5 Goettingen minipigs), 3 injection protocols were compared in dynamic thoracic CTA: (a) DF injection protocol at 80 kV with a iodine delivery rate (IDR) of 0.9 gI/s, a flowrate of 5 mL/s injected with a 60%/40% ratio of iopromide (300 mgI/mL) and saline (dose contrast medium 180 mgI/kg body weight [BW]); (b) reference CTA was performed at 120 kV and a 40% higher iodine dose applied at higher IDR (1.5 gI/s, 5 mL/s iopromide [300 mgI/mL]; no simultaneously administered saline; 300 mgI/kg BW); and (c) conventional single-flow (SF) protocol with identical IDR as the DF protocol at 80 kV (0.9 gI/s, 3 mL/s iopromide [300 mgI/mL]; no simultaneously administered saline; 180 mgI/kg BW). All 3 injection protocols are followed by a saline chaser applied at the same flow rate as the corresponding CM injection. Time attenuation curves representing the vascular bolus shape were generated for pulmonary trunk and descending aorta.
RESULTS: In the circulation phantom, pulmonary and aortic time attenuation curves for the 80 kV DF injection protocols do not significantly differ from the 80 kV SF and the 120 kV SF reference. In the animal model, the 80 kV DF protocol shows similar pulmonal and aortic peak enhancement when compared with the 120 kV SF and 80 kV SF protocols. Also, the bolus length above an attenuation level of 300 HU reveals no significant differences between injection protocols. However, the time to peak was significantly shorter for the 80 kV DF when compared with the 80 kV SF protocol (15.78 ± 1.9 seconds vs 18.24 ± 2.0 seconds; P = 0.008).
CONCLUSION: DualFlow injection protocols can be tailored for low-kV CTA by reducing the IDR while overall flow rate remains unchanged. Although no differences in attenuation were found, DF injections offer a shorter time to peak closer to the reference 120 kV protocol.This allows the use of DF injection protocols to calibrate bolus density in low-kV CTA and yields the potential for a more individualized CM administration.
引用
- Overhoff D, Jost G, McDermott M, et al. Contrast Saline Mixture DualFlow Injection Protocols for Low-Kilovolt Computed Tomography Angiography: A Systematic Phantom and Animal Study. Invest Radiol. 2020. PMID: 33156586. doi:10.1097/RLI.0000000000000706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。